Table 2: Clinicopathologic features of patients according to MSI status.
Feature |
|
MSI |
MSS |
p value |
Stage |
I |
5 (26.3%) |
35 (43.8%) |
0.014 |
II |
6 (31.6%) |
35 (43.8%) |
|
|
III |
8 (42.1%) |
8 (10%) |
|
|
IV |
0 (0%) |
2 (2.5%) |
|
|
Stage |
I, II |
11 (57.9%) |
70 (87.5%) |
0.006 |
III,IV |
8 (42.1%) |
10 (12.5%) |
|
|
Myometrial invasion |
< 1/2 |
9 (47.4%) |
42 (52.5%) |
0.883 |
≥ 1/2 |
10 (52.6%) |
38 (47.5%) |
|
|
Low uterine Segment + |
No |
9 (47.4%) |
37 (46.3%) |
1.000 |
Yes |
10 (52.6%) |
43 (53.8%) |
|
|
LVÄ° |
No |
9 (50%) |
57 (71.3%) |
0.145 |
Yes |
9 (50%) |
23 (28.8%) |
|
|
Grade |
1 |
2 (10.5%) |
24 (30.4%) |
0.080 |
2 |
13 (68.4%) |
32 (40.5%) |
|
|
3 |
4 (21.1%) |
23 (29.1%) |
|
|
Lymph node + |
No |
12 (63.2%) |
60 (89.6%) |
0.012 |
Yes |
7 (36.8%) |
7 (10.4%) |
|
|
Age |
< 60 |
12 (63.2%) |
26 (32.5%) |
0.027 |
≥ 60 |
7 (36.8%) |
54 (67.5%) |
|
|
Local recurrence |
No |
17 (89.4%) |
73 (91.2%) |
0.586 |
Yes |
2 (10.5%) |
7 (8.7%) |
|
|
Distant recurrence |
No |
18 (94.7%) |
78 (97.5%) |
0.141 |
Yes |
1 (5.2%) |
2 (2.5%) |
|